09/09/2013
https://congress.gov...
"This should have been an ongoing exercise over the last decade, in my opinion."
"I also want to take a minute to applaud my friend from Oregon, Rep. Schrader, and Rep. Bilirakis, for working together on pursuing additional ways to promote more generic competition."
"It is important. I am glad we are able to come together in a bipartisan fashion to make this happen."
"Reauthorizing improved generic and biosimilar user fee programs will lead to timelier approvals and lower drug costs. It's that simple."